Immuno-oncology market set to grow in billions, but access concerns remain
Pharmaceutical Technology
MAY 26, 2023
This high compound annual growth rate of 23.6% These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028. In China, immuno-oncology agents manufactured by Western companies are often only accessible with private insurance, based on a Chinese KOL.
Let's personalize your content